• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Takamatsu Kimiharu  高松 公晴

ORCIDConnect your ORCID iD *help
Researcher Number 00649874
Affiliation (Current) 2025: 慶應義塾大学, 医学部(信濃町), 講師(非常勤)
Affiliation (based on the past Project Information) *help 2025: 慶應義塾大学, 医学部(信濃町), 講師(非常勤)
2023: 慶應義塾大学, 医学部(信濃町), 非常勤講師
2022 – 2023: 慶應義塾大学, 医学部(信濃町), 訪問研究員
2020 – 2021: 慶應義塾大学, 医学部(信濃町), 共同研究員
2019: 慶應義塾大学, 医学部(信濃町), 助教
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / Basic Section 56030:Urology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
薬物療法 / 免疫チェックポイント分子 / 免疫チェックポイント阻害剤 / TIGIT / LAG-3 / 腫瘍免疫微小環境 / 腎細胞癌 / TLS / 癌免疫微小環境 / 腫瘍微小環境 / 透析腎癌 / TIM-3
  • Research Projects

    (3 results)
  • Research Products

    (9 results)
  • Co-Researchers

    (6 People)
  •  3次元空間シングルセル解析による腎癌免疫微小環境の解明Principal Investigator

    • Principal Investigator
      高松 公晴
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Keio University
  •  Uncovering the biology of new immune-checkpoint molecule inhibitor and that impact for micro immune microenvironmentPrincipal Investigator

    • Principal Investigator
      Takamatsu Kimiharu
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Keio University
  •  Basic Research on Novel Treatment for Dialysis Kidney Cancer Using Immune Checkpoint Molecular AntibodiesPrincipal Investigator

    • Principal Investigator
      Takamatsu Kimiharu
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Keio University

All 2023 2022 2021 2020

All Journal Article Presentation

  • [Journal Article] Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer2023

    • Author(s)
      Izawa Mizuki、Tanaka Nobuyuki、Murakami Tetsushi、Anno Tadatsugu、Teranishi Yu、Takamatsu Kimiharu、Mikami Shuji、Kakimi Kazuhiro、Imamura Takeshi、Matsumoto Kazuhiro、Oya Mototsugu
    • Journal Title

      Laboratory Investigation

      Volume: 103 Issue: 4 Pages: 100040-100040

    • DOI

      10.1016/j.labinv.2022.100040

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K09411, KAKENHI-PROJECT-21K19414, KAKENHI-PROJECT-22K16794, KAKENHI-PROJECT-19K07468, KAKENHI-PROJECT-20K18151, KAKENHI-PROJECT-22K16823
  • [Journal Article] Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma2023

    • Author(s)
      Anno Tadatsugu、Tanaka Nobuyuki、Takamatsu Kimiharu、Hakozaki Kyohei、Kufukihara Ryohei、Baba Yuto、Takeda Toshikazu、Matsumoto Kazuhiro、Morita Shinya、Kosaka Takeo、Mikami Shuji、Nishihara Hiroshi、Mizuno Ryuichi、Oya Mototsugu
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: - Issue: 6 Pages: 1779-1788

    • DOI

      10.1007/s00262-023-03369-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09411, KAKENHI-PROJECT-21K19414, KAKENHI-PROJECT-22K16794, KAKENHI-PROJECT-19K07468, KAKENHI-PROJECT-23K24476
  • [Journal Article] Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma2022

    • Author(s)
      Kufukihara Ryohei、Tanaka Nobuyuki、Takamatsu Kimiharu、Niwa Naoya、Fukumoto Keishiro、Yasumizu Yota、Takeda Toshikazu、Matsumoto Kazuhiro、Morita Shinya、Kosaka Takeo、Aimono Eriko、Nishihara Hiroshi、Mizuno Ryuichi、Oya Mototsugu
    • Journal Title

      British Journal of Cancer

      Volume: 127 Issue: 6 Pages: 1133-1141

    • DOI

      10.1038/s41416-022-01895-3

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K09356, KAKENHI-PROJECT-21K19414, KAKENHI-PROJECT-22K16794, KAKENHI-PROJECT-23K24476
  • [Journal Article] Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer2022

    • Author(s)
      Masuda Tsukasa、Tanaka Nobuyuki、Takamatsu Kimiharu、Hakozaki Kyohei、Takahashi Ryohei、Anno Tadatsugu、Kufukihara Ryohei、Shojo Kazunori、Mikami Shuji、Shinojima Toshiaki、Kakimi Kazuhiro、Tsunoda Tatsuhiko、Aimono Eriko、Nishihara Hiroshi、Mizuno Ryuichi、Oya Mototsugu
    • Journal Title

      Journal for ImmunoTherapy of Cancer

      Volume: 10 Issue: 3 Pages: 1-12

    • DOI

      10.1136/jitc-2021-003883

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03792, KAKENHI-PROJECT-21K19414, KAKENHI-PROJECT-21K07156, KAKENHI-PROJECT-22K16794, KAKENHI-PROJECT-19K07468
  • [Journal Article] Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy2021

    • Author(s)
      Kimiharu Takamatsu
    • Journal Title

      Nature Communications

      Volume: 12 Issue: 1 Pages: 5547-5547

    • DOI

      10.1038/s41467-021-25865-0

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K16807, KAKENHI-PROJECT-19H05656, KAKENHI-PROJECT-19H03792, KAKENHI-PROJECT-19K07468, KAKENHI-PROJECT-21K19414
  • [Presentation] Uncovering LAG-3 related tumor immunology in renal cell carcinoma and pan-cancer evaluation.2023

    • Author(s)
      Kimiharu Takamatsu
    • Organizer
      American Society of Clinical Oncology Annual meeting 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K16794
  • [Presentation] Novel prognostification model for clear cell renal cell carcinoma: Proposing the immune-based clustering algorithm using future immune-checkpoint targets2020

    • Author(s)
      Takamatsu Kimiharu
    • Organizer
      114th American Urological Association Annual Meeting: Washington D.C., USA
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K16807
  • [Presentation] The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients2020

    • Author(s)
      Takamatsu Kimiharu
    • Organizer
      American Society of Clinical Oncology Annual meeting 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K16807
  • [Presentation] Xp11.2転座型腎細胞癌における腫瘍周囲微小免疫環境の評価2020

    • Author(s)
      高松公晴
    • Organizer
      第29回日本小児泌尿器科学会
    • Data Source
      KAKENHI-PROJECT-19K16807
  • 1.  TANAKA Nobuyuki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 2.  大家 基嗣
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 3.  久冨木原 良平
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 4.  三上 修治
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 5.  水野 隆一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 6.  案納 忠譜
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi